EHA 2021: Video interview with Martin Hutchings, MD who discusses long term follow up of a study examining brentuximab vedotin combined with chemotherapy for first line treatment of Hodgkin lymphoma.
Home / Resource Library / Phase III ECHELON-1 study: Updated results of brentuximab vedotin + chemotherapy for untreated cHL